Research Article
Identification of Malassezia globosa as a Gastric Fungus Associated with PD-L1 Expression and Overall Survival of Patients with Gastric Cancer
Table 1
Baseline characteristics of the study subjects (
).
| | Characteristics | Median (range)/number (%) |
| | Age (years) | 56 (22-86) | | Gender | | | Male | 43 (70.5%) | | Female | 18 (29.5%) | | Body mass index (kg/m2) | 22.1 (16.6-35.1) | | Tumor size (max, cm) [median (range)] | 4.6 (0.5-15) | | Tumor location | | | Upper | 19 (31.1%) | | Middle | 12 (19.7%) | | Lower | 30 (49.2%) | | Tumor differentiation | | | High | 4 (6.5%) | | Moderate | 19 (31.1%) | | Poor | 38 (62.3%) | | Lauren classification | | | Diffuse | 36 (59.0%) | | Intestinal | 17 (27.9%) | | Mix | 8 (13.1%) | | pTNM stage | | | I | 6 (9.8%) | | II | 9 (14.8%) | | III | 34 (55.7%) | | IV | 12 (19.7%) | | Lymphatic vessel invasive (D2-40) | | | Positive | 20 (32.8%) | | Negative | 41 (67.2%) | | Vascular invasive (CD31) | | | Positive | 15 (24.6%) | | Negative | 46 (75.4%) | | Nerve invasive (S-100) | | | Positive | 46 (75.4%) | | Negative | 15 (24.6%) | | HER2 status | | | 0/1+/2+ | 53 (86.9%) | | 3+ | 8 (13.1%) | | PD-L1 status | | | CPS ≥ 10 | 24 (39.3%) | | CPS < 10 | 37 (60.7%) | | Postoperative treatment | | | None | 6 (9.8%) | | Chemotherapy | 41 (67.2%) | | Chemotherapy+anti-PD-1 immunotherapy | 14 (23.0%) |
|
|
